Investment
Features
FeesSafety
Academy
More
Pluang+

Silver Point leads $650M loan for Stryten's acquisition of C&D Trojan, creating a major battery manufacturing platform.

Company Fundamentals
07 Oct 2026
PRNewsWire
View Source
Bullish
Silver Point leads $650M loan for Stryten's acquisition of C&D Trojan, creating a major battery manufacturing platform.

Silver Point Capital's Direct Lending business led a $650 million term loan to finance Stryten Energy's acquisition of C&D Technologies and Trojan Battery Company. This merger forms a leading battery manufacturing platform with 18 facilities across the US, Mexico, and China, serving diverse sectors including transportation and military. Silver Point continues its partnership with Stryten, supporting growth and enhanced service capabilities. The acquisition closed on October 1, 2026, positioning the combined company as a key player in energy storage solutions.

Silver Point Capital's financing deal for Stryten Energy's acquisition of C&D Trojan is the subject, with Pluang's Industrials sector market data as context. As of Oct 07, 2026 19:12 WIB, out of 93 priced Industrials-sector US stocks tradable on Pluang, 25 rose and 65 fell. Notable movers include ZIM at USD 30.10 with a 3.08% increase and a typical hold time of 27 days, PL at USD 18.00 down 3.07% with 57% sell order activity, and EOSE at USD 3.17 down 2.76% with 54% sell order activity.

More News

Hormel Foods price target cut to $23 amid hopes for valuation rebound despite 50% share drop.

Hormel Foods price target cut to $23 amid hopes for valuation rebound despite 50% share drop.

BNP Paribas lowered Hormel Foods' price target from $26 to $23, indicating a potential 16.2% upside from its current price of around $19.80. Despite a 50.5% decline in its share price over five years, Hormel Foods remains attractive for dividend inve...

Analyst Insights
Neutral
58 minutes ago
Barclays rates Becton Dickinson 'Underweight' amid $3B U.S. manufacturing partnership

Barclays rates Becton Dickinson 'Underweight' amid $3B U.S. manufacturing partnership

Barclays initiated coverage of Becton, Dickinson and Company (BDX) with an "Underweight" rating, indicating a cautious outlook for the medical technology stock. BDX is partnering with the U.S. government to boost domestic manufacturing and strengthen...

Market News
Bearish
1 hour ago
Morgan Stanley raises Eli Lilly price target to $1,430, signaling 20.8% potential upside.

Morgan Stanley raises Eli Lilly price target to $1,430, signaling 20.8% potential upside.

Morgan Stanley increased its price target for Eli Lilly to $1,430 from $1,419, maintaining an Overweight rating. This new target implies a potential upside of about 20.8% from the current share price of around $1,184. The adjustment reflects updated ...

Analyst Insights
Bullish
1 hour ago
Arthur J. Gallagher sees 6% organic growth; analysts split on price targets amid mixed outlook.

Arthur J. Gallagher sees 6% organic growth; analysts split on price targets amid mixed outlook.

Arthur J. Gallagher expects about 6% organic growth in Q3, driven by strong client retention and new business despite easing property insurance pricing. Cantor Fitzgerald lowered its price target to $280, below the $288 average from 19 analysts who m...

Analyst Insights
Bullish
3 hours ago
Zscaler's price target raised to $255 on strong AI-driven cybersecurity demand and growth outlook.

Zscaler's price target raised to $255 on strong AI-driven cybersecurity demand and growth outlook.

Needham raised Zscaler's price target to $255, citing strong demand for AI-related cybersecurity solutions. Zscaler aims to exceed $8 billion in annual recurring revenue by fiscal 2031, driven by increasing needs to protect against AI-powered cyberat...

Analyst Insights
Bullish
3 hours ago
banner-footerbanner-footer

Invest & Trade with
#1 Award-Winning Investment Super App